ISRAEL ACQUISITIONS CORP Accretion Expense
ISRAEL ACQUISITIONS CORP (ISRL) reported Accretion Expense of $46.66 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-11-13
- ISRAEL ACQUISITIONS CORP accretion expense for the quarter ending 2022-09-30 was $10.51K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month |
|---|---|---|---|
| 2022-09-30 | $10.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $46.66K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $36.15K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aimei Health Technology Co., Ltd. (AFJK) | United States | $0.038B | |
| CO2 Energy Transition Corp. (NOEM) | United States | $0.040B | |
| Innventure, Inc. (INV) | United States | $0.068B | -2.99 |
| Origin Investment Corp I (ORIQ) | $0.090B | 13.93 | |
| XFLH Capital Corp (XFLH) | United States | $0.139B | |
| Aldel Financial II Inc. (ALDF) | United States | $0.323B |